Canada · Delayed Price · Currency is CAD Richards Group Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 5% year-to-date, led by healthcare, while packaging declined due to U.S. macro headwinds. Gross margins improved from tariff refunds and operational efficiencies, with free cash flow conversion at 67%. Leverage increased from acquisitions and buybacks, but remains within target.
-
Revenue grew 5% year-over-year to CAD 105 million, led by healthcare and OEM gains, while gross margin improved to 44%. EBITDA was flat as higher OpEx offset margin gains, and leverage rose following major M&A and share buybacks. Packaging remains challenged amid macro headwinds.
Fiscal Year 2025
-
Fiscal 2025 saw 5.5% revenue growth driven by healthcare acquisitions, while adjusted EBITDA margin declined due to higher costs. Major M&A expanded the healthcare portfolio and global reach, and a new long-term strategy aims for international growth and operational optimization.